Post-MPN AML: Real-World Outcomes and Ongoing Challenges

Have newer therapies improved outcomes for patients with acute myeloid leukemia after myeloproliferative neoplasms, or post-MPN AML? In this episode of CancerSpeak, Cancer Hematologic Malignancies Section Editor Dr. Courtney DiNardo is joined by Dr. Jan Philipp Bewersdorf and Dr. Anand Patel to discuss an article in Cancer evaluating real-world outcomes among patients with post-MPN AML in the United States. Their conversation explores survival trends in the era of novel therapies, barriers to allogeneic hematopoietic cell transplantation, and future directions for improving outcomes in this rare, high-risk disease. Read the accompanying article in Cancer: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70415 Follow Cancer on social media: x.com/JournalCancer instagram.com/acsjournals linkedin.com/company/acs-journals Original music by J. Gilman.